The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.

The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.

Item
http://www.wikidata.org/entity/Q54515616
The contribution of resident vascular stem cells to arterial pathologyPhase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors.Hip osteoarthritis and osteoporosis: clinical and histomorphometric considerations.Adult adipose-derived stem cells and breast cancer: a controversial relationship.PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.Molecular profiling of childhood cancer: Biomarkers and novel therapiesThe potential of heparanase as a therapeutic target in cancerAntitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.The biomolecular basis of adipogenic differentiation of adipose-derived stem cells.Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.Reconstruction of Alar Nasal Cartilage Defects Using a Tissue Engineering Technique Based on a Combined Use of Autologous Chondrocyte Micrografts and Platelet-rich Plasma: Preliminary Clinical and Instrumental Evaluation.Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?Diabetes and aging: a different phenotypic commitment of circulating and resident stem cells?Comparison of tissue transglutaminase 2 and bone biological markers osteocalcin, osteopontin and sclerostin expression in human osteoporosis and osteoarthritis.
P2860

The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.

Item
http://www.wikidata.org/entity/Q54515616
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The curative efficacy of namit ...... d with antiangiogenic effects.
@en
The curative efficacy of namitecan
@nl
type
label
The curative efficacy of namit ...... d with antiangiogenic effects.
@en
The curative efficacy of namitecan
@nl
prefLabel
The curative efficacy of namit ...... d with antiangiogenic effects.
@en
The curative efficacy of namitecan
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
The curative efficacy of namit ...... d with antiangiogenic effects.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698